Brain radiotherapy added to first-line immunochemotherapy improves survival in patients with treatment-naïve, driver-negative lung adenocarcinoma and synchronous brain metastases

ObjectiveThe optimal integration of brain radiotherapy with first-line immunochemotherapy for treatment-naïve, driver-negative lung adenocarcinoma patients with synchronous brain metastases remains unclear. This study assessed the efficacy and safety of this combined strategy.MethodologyIn this retr...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Rui Wang, Jianxi Zhou, Li Xiao, Hongling Lu, Yaru Kong, Yongchao Yu, Yunchuan Sun, Jiaju Zhang, Yingnan Zhou
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	Frontiers Media S.A. 2026-03-01
Saila:	Frontiers in Oncology
Gaiak:	brain metastases immunotherapy intracranial progression-free survival non-small cell lung cancer overall survival radiotherapy
Sarrera elektronikoa:	https://www.frontiersin.org/articles/10.3389/fonc.2026.1808429/full
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!